Healthcare Microfluidics Market Growth Analysis, Opportunities, Trends, Developments and Forecast to 2027 – Abbott Laboratories, Agilent Technologies

The Healthcare Microfluidics market research report provides an in-depth analysis of the current’s trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2021 and 2027 and also provides the forecast data from year 2021 to 2027 which is based on revenue. With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Healthcare Microfluidics market research report recommends a business strategy for present market participants to strengthen their position in the market.

The data studied for the preparation of the report takes into account the current major players and the major players that will be listed. Industry top players are: Abbott Laboratories, Agilent Technologies, Inc., BD, Bio-Rad Laboratories, Danaher Corporation, Roche, IDEX Corporation, PerkinElmer, Thermo Fisher Scientific

The Global Healthcare Microfluidics Market Size is Projected to Reach at a CAGR of 23.22% during 2021-2027.

Click Here To DOWNLOAD Sample Copy:

Recent Developments

In November 2020, Dolomite Microfluidics and MilliporeSigma collaborated to release off-the-shelf NanoFabTx microfluidic device kits for the production of PLGA nano- and microparticles for drug development and controlled drug release applications.

In March 2020, the FDA approved the use of Cepheid’s GeneXpert rapid molecular diagnostic machines to test for the new coronavirus. The module uses disposable cartridges, pre-filled with the required chemicals that are channeled around test chambers using microfluidics.

Covid-19 Impact and Recovery Analysis:

The number one goal of this Healthcare Microfluidics Market document is to provide Quantitative records withinside the form of charts and graphs. The information regarding market fundamentals is provided surely for the sake of readers. All the readers on the side of stakeholders will understand the market situations and business enterprise environment because it needs to be through this properly-planned Market analysis. It turns smooth to collect the effect of COVID-19 on the market boom through this Healthcare Microfluidics market document.

Healthcare Microfluidics market Segmentation By Type:

Glass Based

Polymer Based

Silicon Based


Healthcare Microfluidics market Segmentation By Application:




For The Full Report Click here:

Key Market Trends

The Point-of-Care Diagnostics Segment is Expected to Show a High CAGR in the Upcoming Years

Point-of-care diagnostics (POC) is believed to act as an integral part of healthcare, especially in the diagnostics of diseases. Microfluidics technology is well-suited for point-of-care diagnostics. This technology has the potential to offer rapid and affordable point-of-care diagnostic tools to help during the COVID-19 pandemic.

The major advantages associated with the devices are rapid and precise response, cost-effectiveness, and portability. Research is being done in point-of-care diagnostics to develop a chip-based device, which can examine multiple analytes in complex samples. Hence, the integration of microfluidics is believed to contribute to the improvisation of point-of-care diagnostics.

Regional Analysis:

North America Dominates the Market and is Expected to do the Same in the Forecast Period

North America dominates the microfluidics market, which is majorly attributed to factors such as the well-established healthcare system and the higher adoption of novel therapeutics among the general population.

Microfluidics is a vastly growing field in the United States with a high budget for R&D. In 2018, US healthcare accounted for 17.9% of the GDP. The United States is one of the major destinations for all the recent advancements. The point-of-care diagnostics uses microfluidic technology for various applications, like molecular diagnostics, infectious diseases, and chronic diseases, which aim to produce integrated microfluidic devices that are easy to use and rapid.

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)


Significant Features and Key Highlights of the Reports:

– Detailed overview of Healthcare Microfluidics Market

– Changing market dynamics of the industry

– In-depth Healthcare Microfluidics market segmentation by Type, Application etc.

– Historical, current and projected market size in terms of volume and value.

– Recent industry trends and developments

– Competitive landscape of Healthcare Microfluidics Market

– Strategies of key players and product offerings

– Potential and niche segments/regions exhibiting promising growth.

The report gives answers to the following:

  • What strategies are followed by key players to fight this Covid-19 situation?
  • What are the essential matters drivers, opportunities, challenges, and dangers of the market will face surviving?
  • Which are the leading market players in the Healthcare Microfluidics industry?
  • What is the predicted compound annual growth rate (CAGR) of the global marketplace during the forecast period (2021-2027)?
  • What could be the anticipated value of the Healthcare Microfluidics marketplace in the during the forecast period?
  • Impact of COVID-19:

The research includes historic data from 2016 to 2021 and forecasts until 2027 which makes the Healthcare Microfluidics market report an invaluable resource for industry executives, marketing, sales, and product managers, consultants, analysts, and other people looking for key industry data in readily accessible documents with clearly presented tables and graphs.

Customization: –

The Global Healthcare Microfluidics Market report may be modified to meet your specific business needs. Because we understand what our clients want, we provide up to 20% customization for any of our Market Intelligence Data reports at no additional cost to all of our Users.

About Us:

Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact Us:

Irfan Tamboli (Head of Sales)MARKET INTELLIGENCE DATA
Phone: +1 (704) 266-3234
Mail to:

Leave a Reply

Your email address will not be published. Required fields are marked *